239 related articles for article (PubMed ID: 32542790)
1. Dosing Recommendations for Pediatric Patients With Renal Impairment.
Al-Khouja A; Park K; Anderson DJC; Young C; Wang J; Huang SM; Khurana M; Burckart GJ
J Clin Pharmacol; 2020 Dec; 60(12):1551-1560. PubMed ID: 32542790
[TBL] [Abstract][Full Text] [Related]
2. Strength of evidence for labeled dosing recommendations in renal impairment.
Gagne JJ; Khan NF; Raj TS; Patel LR; Choudhry NK
Clin Trials; 2017 Apr; 14(2):219-221. PubMed ID: 27780884
[TBL] [Abstract][Full Text] [Related]
3. Methods Used for Pediatric Dose Selection in Drug Development Programs Submitted to the US FDA 2012-2020.
Green FG; Park K; Burckart GJ
J Clin Pharmacol; 2021 Jun; 61 Suppl 1():S28-S35. PubMed ID: 34185898
[TBL] [Abstract][Full Text] [Related]
4. Transient impact of automated glomerular filtration rate reporting on drug dosing for hospitalized older adults with concealed renal insufficiency.
Kalender-Rich JL; Mahnken JD; Wetmore JB; Rigler SK
Am J Geriatr Pharmacother; 2011 Oct; 9(5):320-7. PubMed ID: 21920825
[TBL] [Abstract][Full Text] [Related]
5. A Call for Objective Dose Selection to Increase Success in Pediatric Clinical Trials: A Perspective From NICHD and NIMH Program Staff.
Giacoia G; Grabb MC; Pawlyk AC; Ren Z; Samedy-Bates L; Taylor-Zapata P
J Clin Pharmacol; 2021 Jun; 61 Suppl 1():S9-S12. PubMed ID: 34185908
[No Abstract] [Full Text] [Related]
6. Drug dosage adjustment of patients with impaired renal function at hospital discharge in a teaching hospital.
Sah SK; Wanakamanee U; Lerkiatbundit S; Regmi BM
J Nepal Health Res Counc; 2014 Jan; 12(26):54-8. PubMed ID: 25574986
[TBL] [Abstract][Full Text] [Related]
7. Progress in Drug Development-Pediatric Dose Selection: Workshop Summary.
Wang J; van den Anker JN; Burckart GJ
J Clin Pharmacol; 2021 Jun; 61 Suppl 1():S13-S21. PubMed ID: 34185909
[TBL] [Abstract][Full Text] [Related]
8. Dose adjustment guidelines for medications in patients with renal impairment: how consistent are drug information sources?
Khanal A; Castelino RL; Peterson GM; Jose MD
Intern Med J; 2014 Jan; 44(1):77-85. PubMed ID: 24112311
[TBL] [Abstract][Full Text] [Related]
9. Clinical evidence supporting pharmacogenomic biomarker testing provided in US Food and Drug Administration drug labels.
Wang B; Canestaro WJ; Choudhry NK
JAMA Intern Med; 2014 Dec; 174(12):1938-44. PubMed ID: 25317785
[TBL] [Abstract][Full Text] [Related]
10. Renal Impairment in Pediatric Patients: Current Approaches to Drug Dosing.
Khurana M
J Clin Pharmacol; 2021 Jun; 61 Suppl 1():S161-S164. PubMed ID: 34185911
[No Abstract] [Full Text] [Related]
11. How to optimise antimicrobial prescriptions in the Intensive Care Unit: principles of individualised dosing using pharmacokinetics and pharmacodynamics.
Roberts JA; Joynt GM; Choi GY; Gomersall CD; Lipman J
Int J Antimicrob Agents; 2012 Mar; 39(3):187-92. PubMed ID: 22226651
[TBL] [Abstract][Full Text] [Related]
12. Review of the Best Pharmaceuticals for Children Act and the Pediatric Research Equity Act: What can the obstetric community learn from the pediatric experience?
Ren Z; Zajicek A
Semin Perinatol; 2015 Nov; 39(7):530-1. PubMed ID: 26455383
[TBL] [Abstract][Full Text] [Related]
13. International Coherence of Pediatric Drug Labeling for Drug Safety: Comparison of Approved Labels in Korea and the United States.
Song YK; Han N; Burckart GJ; Oh JM
Clin Pharmacol Ther; 2020 Mar; 107(3):530-540. PubMed ID: 31544241
[TBL] [Abstract][Full Text] [Related]
14. Development of the Swiss Database for dosing medicinal products in pediatrics.
Tilen R; Panis D; Aeschbacher S; Sabine T; Meyer Zu Schwabedissen HE; Berger C
Eur J Pediatr; 2022 Mar; 181(3):1221-1231. PubMed ID: 34739591
[TBL] [Abstract][Full Text] [Related]
15. A comparison of Canadian general pediatric dosing publications.
Dayneka N
Can J Clin Pharmacol; 2003; 10(3):107-10. PubMed ID: 14506508
[TBL] [Abstract][Full Text] [Related]
16. Can de facto dosing practices bridge the knowledge gap in pediatric medication recommendations?
Scheufele EL; Dubey A
AMIA Annu Symp Proc; 2009 Nov; 2009():573-7. PubMed ID: 20351920
[TBL] [Abstract][Full Text] [Related]
17. Potentially inappropriate prescribing of renally cleared drugs in elderly patients in community and aged care settings.
Khanal A; Peterson GM; Castelino RL; Jose MD
Drugs Aging; 2015 May; 32(5):391-400. PubMed ID: 25925940
[TBL] [Abstract][Full Text] [Related]
18. Inappropriate Medication in Non-Hospitalized Patients With Renal Insufficiency: A Systematic Review.
Dörks M; Allers K; Schmiemann G; Herget-Rosenthal S; Hoffmann F
J Am Geriatr Soc; 2017 Apr; 65(4):853-862. PubMed ID: 28240771
[TBL] [Abstract][Full Text] [Related]
19. Improving pediatric dosing through pediatric initiatives: what we have learned.
Rodriguez W; Selen A; Avant D; Chaurasia C; Crescenzi T; Gieser G; Di Giacinto J; Huang SM; Lee P; Mathis L; Murphy D; Murphy S; Roberts R; Sachs HC; Suarez S; Tandon V; Uppoor RS
Pediatrics; 2008 Mar; 121(3):530-9. PubMed ID: 18310202
[TBL] [Abstract][Full Text] [Related]
20. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
